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Paradoxical growth (PG) has been described for echinocandins and is characterized by cell growth at drug
concentrations above the MIC. In this study, two isolates each of Candida albicans, C. tropicalis, C. orthopsilosis,
and C. parapsilosis, all of which displaying PG in response to caspofungin, were subjected to MIC, minimal
fungicidal concentration (MFC), and time-kill curve assays to evaluate the levels of PG. Cell wall components
and ultrastructural modifications of the PG cells were also investigated. The results showed that when cell
growth and survival were evaluated by MFC or time-kill curve assays, high concentrations of caspofungin did
not show fungicidal activity against PG cells. Furthermore, for C. parapsilosis and C. orthopsilosis, time-kill
curves were more discriminatory than MFCs in detecting the PG effect. The four different Candida species
studied demonstrated similar alterations in cell wall components and ultrastructure associated with PG. In PG
cells, -1,3-glucan content decreased from 2.7- to 7.8-fold, whereas chitin content increased from 4.0- to
6.6-fold. An electron microscopy study of the PG cells revealed morphological alterations, clumping of cells,
enlarged cells, the absence of filamentation, abnormal septa, and accumulation of chitin in the cell wall. Also,
PG cells basically exhibited a single dark high-density layer in the cell wall, indicating the loss of the
-1,3-glucan layer. Our results present novel details about the ultrastructural alterations that occur in C.
albicans, C. parapsilosis, C. orthopsilosis, and C. tropicalis during PG and show that chitin is the major
component of the cell walls of PG cells. Stimulation of chitin synthesis may represent a rescue mechanism
against caspofungin activity.
Caspofungin (CAS), the first echinocandin to be commer-
cialized worldwide, exerts its antifungal effect by blocking the
Fks1 subunit of glucan synthase, the enzyme responsible for
-1,3-glucan biosynthesis (12, 13, 20). Candida isolates are
generally susceptible, in vitro and in vivo, to low concentrations
of CAS, typically exhibiting MICs of 0.5 g/ml (29). An
exception is Candida parapsilosis, which generally shows MIC90
values ranging from 0.5 to 1.0 g/ml (18, 30) when tested by
broth microdilution assay, according to Clinical and Labora-
tory Standards Institute (CLSI) guidelines (10). CAS is there-
fore considered to be fungicidal to most Candida species, with
some exceptions, including C. parapsilosis and C. guilliermondii
strains, as both of which generate higher MIC and minimal
fungicidal concentration (MFC) values (3).
Although CAS shows excellent growth-inhibitory activity at
low concentrations, paradoxical growth (PG) in the presence
of this compound has been observed in Candida spp. PG has
been described as cell growth in the presence of CAS concen-
trations that are at least two concentrations above the MIC in
broth microdilution susceptibility tests, performed according
to CLSI guidelines (7, 22, 34). Unlike trailing growth, in which
reduced but persistent cell growth at all drug concentrations
above the MIC is observed, PG is defined as a resurgence of
growth in the presence of supra-MICs of a drug; such growth
is often close to the levels achieved in the absence of drug (22).
Studies describing PG in Candida spp. have demonstrated
that there are differences in the frequency of PG in vitro that
are echinocandin specific and Candida species related (7, 15,
37). Despite the fact that PG occurs in the presence of high
concentrations of echinocandins, it has been shown that this
phenomenon is not due to the selection of a resistant subpopu-
lation but, in part, to compensatory mechanisms of synthesis of
cell wall components (35, 38).
The clinical relevance of PG has not yet been fully deter-
mined. Data obtained using animal models are still rare and
controversial (9). Interestingly, a randomized comparative
study of the use of two micafungin dosages to treat patients
with candidemia reported that patients with persistently posi-
tive blood cultures were more frequently observed in a group
treated with 150 mg/day micafungin (23 patients; 11.6%) than
those observed in a group treated with 100 mg/day micafungin
(11 patients; 5.8%). The average time to register the first
negative blood culture for Candida was 2 days for the group
treated with 100 mg/day micafungin and 3 days for the group
treated with 150 mg/day of the compound (28).
The occurrence of PG after exposure to echinocandins has
been characterized mostly with C. albicans strains (35); thus, it
is not clear whether the physiological and morphological ad-
aptations described may be applied to other Candida species.
The aim of this study is to characterize the morphological and
biochemical features related to PG in the following four dif-
ferent Candida species: C. albicans, C. parapsilosis, C. orthop-
silosis, and C. tropicalis.
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MATERIALS AND METHODS
Isolates. PG was screened using the broth microdilution method by testing 77
Candida bloodstream isolates randomly selected from yeast stock cultures from
the Laborato´rio Especial de Micologia, Universidade Federal de Sa˜o Paulo, Sa˜o
Paulo, Brazil. After being screened, eight Candida strains exhibiting PG at
approximately 16 g/ml of caspofungin were selected. These included two strains
of C. albicans, two strains of C. orthopsilosis, two strains of C. parapsilosis, and
two strains of C. tropicalis.
Antifungal susceptibility. Caspofungin (Merck Sharp & Dohme) MICs were
determined by microdilution, as described in the CLSI document M27-A3 (10),
using RPMI 1640 medium at pH 7.0 buffered with morpholinepropanesulfonic
acid (MOPS). MIC endpoints were determined after 24 h based on a prominent
decrease in growth compared to that of the drug-free growth control. Following
the recommendations of the CLSI guidelines, C. krusei ATCC 6258 and C.
parapsilosis ATCC 22019 were used as control strains and were included in each
day of testing. The final CAS concentrations ranged from 0.125 to 64.0 g/ml. In
this assay, PG was defined as growth resurgence in the presence of drug at least
two dilutions above the MIC.
MFC. After MIC readings, 100-l samples above the MIC from each well were
withdrawn and plated in triplicate onto 90-mm Sabouraud dextrose agar (SDA)
plates. The inoculated plates were incubated at 35°C, and MFC were recorded
after 48 h. The MFC was defined as the lowest concentration of drug that
reduced the size of the initial inoculum by at least 99%, as adapted from
Barchiesi et al. (2).
Time-kill curve (TKC). This methodology was adapted from Barchiesi et al.
(3). The isolates were subcultured twice and grown for 24 h at 35°C on SDA
plates. Three to five colonies of each strain were suspended in 10 ml of sterile
distilled water, and the turbidity was adjusted spectrophotometrically to that of
a 0.5 McFarland standard (approximately 1  106 to 5  106 CFU/ml). One
milliliter of adjusted fungal suspension was added to 9 ml of RPMI 1640 medium
buffered with MOPS plus an appropriate amount of CAS. For C. albicans and C.
tropicalis, CAS was used at concentrations of 0.25, 0.5, 2.0, 16.0, and 32.0 g/ml.
For C. parapsilosis and C. orthopsilosis, CAS was used at 0.5, 1.0, 4.0, 16.0, and
32.0 g/ml. Test solutions were incubated at 35°C, and at predetermined time
points (0, 3, 6, 9, 12, 24, and 48 h), 100-l aliquots were removed from each test
solution. After 10-fold serial dilutions, a 100-l aliquot from each dilution was
streaked, in triplicate, onto Sabouraud dextrose agar plates for colony count
determination after incubation at 35°C for 48 h. Fungicidal activity was consid-
ered to be achieved when the number of CFU/ml was reduced by 99% com-
pared to that of the initial inoculum.
Cell wall isolation and carbohydrate composition analysis. Candida cells ob-
tained from 24-h growth in 50 ml of RPMI 1640 medium buffered with MOPS or
in the same medium plus 16.0 g/ml of CAS were used for cell wall component
analysis, as described previously (26, 32, 35). The cells were washed three times
in phosphate-buffered saline (PBS) and disrupted by 100 cycles of freezing and
thawing, followed by agitation with glass beads at 425 to 600 m in diameter
(Sigma-Aldrich, Inc., St. Louis, MI) until no viable cells could be observed by
subculture; disruption was also observed by light microscopy. The cell wall was
isolated, dried, lyophilized, and frozen at 80°C. Isolated cell walls were alkali
extracted three times for 60 min with 500 l of 3% NaOH at 75°C. The pellet was
washed once with 100 mM Tris-HCl (pH 7.5) and once more with 10 mM
Tris-HCl (pH 7.5), then digested with 4 mg/ml Zymolyase 100T (Seikagaku
Corporation, Tokyo, Japan) in 10 mM Tris-HCl (pH 7.5) overnight at 37°C, and
centrifuged for 10 min at 20,000  g at 4°C. The supernatant was split into two
portions. One portion was used for hexose (-1,3- plus -1,6-glucan) quantifi-
cation by the phenol-sulfuric method, as previously described (14, 26, 35), and
the other portion was dialyzed against distilled water using a Spectra/Por mem-
brane, with a molecular weight exclusion of 6,000 to 8,000 (Spectrum Medical
Industries, Inc., Rancho Dominguez, CA), and its hexose content was measured
(-1,6-glucans, resistant to zymolyase treatment). The -1,3-glucan value was
determined by subtraction of the -1,6-glucan value from the value representing
the combination of -1,3- plus -1,6-glucan. Zymolyase-insoluble pellets were
washed once with 10 mM Tris-HCl, pH 7.0, and water. The pellets were used for
measurement of glucosamine content to determine chitin concentrations (24,
35). The pellets were hydrolyzed with 6 N HCl at 100°C for 6 h, and the
hydrolyzates were freed from excess acid by repeated evaporation at reduced
pressure. After removal of the acid, the pellets were resuspended in water, and
the glucosamine content was measured and compared to a standard curve rang-
ing from 0 to 200 mg of D-glucosamine, as previously described (24).
Microscopic analysis. Candida cells obtained from a 24-h culture in RPMI
1640 with 16 g/ml of CAS or without the drug were used for fluorescent
microscopy, transmission electron microscopy (TEM), and scanning electron
microscopy (SEM).
(i) Fluorescence microscopy. The methodology used was adapted from that
used by Walker et al. (36). Cells were collected by centrifugation, washed with
PBS buffer at pH 7.2, and fixed in 10% (vol/vol) neutral buffered formalin
(Sigma-Aldrich). Cells were stained with 5 M calcofluor white (CFW) (Invitro-
gen, Oregon) at 37°C for 10 min. Aliquots of 10 l were placed on glass slides
and examined using a Olympus IX81 motorized microscope (Olympus, Tokyo,
Japan) equipped with fluorescence. Because CFW bind specifically to chitin, this
methodology was used to visualize the chitin in the cell wall. Images were
digitally recorded using CellˆP imaging software and a DP-71 microscope digital
camera (Olympus, Tokyo, Japan). Mean fluorescence intensities were calculated
for at least 20 individual cells for each condition. The exposure time of fluores-
cence images was fixed to observe intensity differences between PG and control
cells. The mean fluorescence intensities of the control cell and PG cells were
compared using the Student t test (Microsoft Office Excel 2003). The significance
level for the P value was considered to be 0.05.
(ii) SEM. This methodology was adapted from that used by Bizerra et al. (4).
The cells were fixed overnight at 4°C in 2.0% formaldehyde plus 2.5% glutaral-
dehyde buffered at pH 7.2 with 0.1 M sodium cacodylate. After fixation, small
drops of the sample were placed on a specimen support coated with poly-L-lysine.
Postfixation was carried out with 1% osmium tetroxide in cacodylate buffer for
1 h. Samples were then treated with 1% tannic acid for 45 min, washed three
times with distilled water for 15 min, and treated again with 1% osmium tetrox-
ide in cacodylate buffer for 1 h. Dehydration was carried out in a graded series
of ethanol. The dehydrated samples were critical-point dried in CO2, coated with
gold, and examined in a Jeol JSM-5300 scanning electron microscope. The
perimeter of the cell was measured using CellˆP imaging software (Olympus,
Tokyo, Japan). The mean of the cell perimeter was then calculated for at least 20
individual cells from each experimental condition. The perimeter values of con-
trol and PG cells were compared using the Student t test (Microsoft Office Excel
2003). The significance level for the P value was considered to be 0.05.
(iii) TEM. Initially, cells were washed in PBS and fixed overnight at 4°C with
2.0% formaldehyde plus 2.5% glutaraldehyde buffered at pH 7.2 with 0.1 M
sodium cacodylate. The fixed cells were postfixed in 1% osmium tetroxide for 1 h
at room temperature. After dehydration in a graded series of ethanol and
treatment with propylene oxide, the cells were embedded in Epon resin. Ultra-
thin sections (60 nm) were contrasted with uranyl acetate and lead citrate and
examined using a transmission electron microscope (Jeol JEM-1200EX II).
RESULTS
CAS susceptibility and PG effect. Of the 77 Candida blood-
stream isolates initially screened, 42 isolates (54.5%) displayed
the phenomenon of PG in the susceptibility test using caspo-
fungin. Of the 42 isolates, two from each species (C. albicans,
C. tropicalis, C. orthopsilosis, and C. parapsilosis) were selected
for additional tests. CAS MICs generated by the broth mi-
crodilution assay were 2.0 g/ml for the eight selected iso-
lates (Table 1). It should be noted that the C. albicans and C.
TABLE 1. Caspofungin MICs and PG patterns of
Candida strains tested
Species Strain CAS MIC(g/ml)
Drug concn
(g/ml)
producing PG
C. albicans 1399 0.5 8.0 and 16.0
1954 0.25 16.0
C. tropicalis 1507 0.25 8.0 and 16.0
1490A 0.5 16.0
C. orthopsilosis 1825 1.0 8.0, 16.0, and 32.0
1238A 1.0 16.0 and 32.0
C. parapsilosis 1856 1.0 16.0 and 32.0
1529A 1.0 16.0 and 32.0
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tropicalis strains showed MIC values between 0.25 and 0.5
g/ml of CAS, whereas C. parapsilosis and C. orthopsilosis
isolates showed MIC values of 1.0 g/ml of CAS. The appear-
ance of PG was confirmed in all eight selected isolates at CAS
concentrations ranging from 8.0 to 32.0 g/ml. Because all
isolates showed PG at 16 g/ml CAS (Table 1), this concen-
tration was chosen for all subsequent experiments, including
electron microscopy, fluorescence microscopy, and cell wall
composition analysis.
MFC. The MFC was used to test the fungicidal activity of
CAS and to confirm PG in the selected isolates. CAS showed
fungicidal activity against the C. albicans and C. tropicalis
strains at lower concentrations than those needed to show
fungicidal activity against the other two strains. Table 2 shows
that, in C. albicans and C. tropicalis, PG was detected at CAS
concentrations between 8 and 32 g/ml; the highest of these
concentrations is at least three drug dilutions above the MFC.
Against C. parapsilosis and C. orthopsilosis isolates (with the
exception of the C. orthopsilosis 1238A isolate) CAS was only
fungistatic; MFC was unable to detect PG in these strains
(Table 2).
TKCs. TKCs confirmed the occurrence of PG in all eight
isolates tested (Fig. 1); however, some differences were ob-
served among the strains tested. C. albicans and C. tropicalis
strains showed similar patterns of TKCs in which the PG effect
was characterized by fungicidal activity at low concentrations
of CAS (0.25, 0.5, and 2.0 g/ml) and fungistatic activity at the
highest concentration (16.0 g/ml). On the other hand, CAS at
concentrations ranging from 0.25 to 32 g/ml had only fungi-
static activity on C. parapsilosis and C. orthopsilosis isolates,
although an exception worth noting is the C. orthopsilosis
1238A isolate, which was killed at lower concentrations of CAS
(2.0 and 4.0 g/ml). In agreement with the MFC assay results,
the TKC results showed that the PG effect occurred at con-
centrations ranging from 16 to 32 g/ml. At drug concentra-
tions that induced PG, a decrease in the CFU count was ob-
served at early incubation times (3 to 6 h), followed by an
increase in the CFU count at later incubation times (9 to 48 h).
A concentration of 16 g/ml CAS proved to be the most
effective for producing the PG effect.
Alterations of cell wall components. When cultivated in the
presence of 16 g/ml CAS, all Candida species analyzed
showed similar cell wall chitin and glucan composition. Cells
cultivated under these conditions showed a significant decrease
in the total amount of cell wall glucan content (Fig. 2A) and a
sharp decrease in the content of -1,3-glucans (Fig. 2B). An
increase in total chitin content was detected in all Candida
species (Fig. 2C). Figure 2D shows that treatment of Candida
species with CAS led to a decrease of 2.9- to 5.0-fold in -1,3-
plus -1,6-glucan, a decrease of 2.7- to 7.8-fold in -1,3-glucan
alone, and an increase of 4.0- to 6.6-fold in chitin.
Microscopic analysis. (i) Fluorescence microscopy. Figure 3
shows fluorescent micrographs of untreated and PG cells of C.
albicans strain 1399 after 24 h of incubation. Because CFW
binds specifically to chitin, the intensity of CFW fluorescence
of cells was comparable to the results of chitin content deter-
mined by our assays of cell wall biochemistry. Control cells
exhibited particularly intense fluorescence layered between
mother cells and buds, with a more homogeneous and less
intense fluorescent signal along the remaining surface of the
cell. Compared to untreated cells, PG cells showed a more
heterogeneous and intense fluorescence around the entire cell
surface, with some regions exhibiting excess chitin, as shown by
accumulation of fluorescence intensity (Fig. 3).
(ii) SEM. As shown in Fig. 4, PG cells exhibited morpho-
logical abnormalities that included (i) budding cells without
clear rings around the constrictions between mother and
daughter cells, (ii) enlarged yeasts forming clumps, and (iii) the
absence of filamentation. These changes were similarly found
in the four Candida species studied. Control cells showed a
normal elliptical shape, budding cells with clear constriction
rings, and the presence of filamentation. Determination of the
size of the cell perimeter confirmed the differences between
control and PG cells of C. albicans (10.86  1.41 and 21.21 
3.57 m, respectively), C. tropicalis (10.76  1.34 and 15.92 
2.28 m, respectively), C. orthopsilosis (8.32  1.32 and
13.21 1.66 m, respectively), and C. parapsilosis (8.59 1.39
and 10.54 1.22 m, respectively). In all cases, the differences
were statistically significant (P  0.001). The average perime-
ter size of control cells of all Candida species was 9.56  1.83
m, whereas PG cells showed an average perimeter size of
15.22  4.56 m (P  0.001).
(iii) TEM. The morphological changes observed in PG cells
by TEM are related mainly to the cell wall structure and
formation of the budding septa (Fig. 5). An abnormal thickness
of the septum was observed between mother and daughter
cells, with no clear separation between the cells (Fig. 5B and F,
black arrows). The cell walls of control and PG cells presented
remarkable differences in morphology (Fig. 5). By means of
conventional TEM, we observed that control cells exhibited a
TABLE 2. Growth distribution of Candida isolates in MFC tests at different CAS
concentrations after 24 h of incubation in RPMI 1640
Isolate
Growth at indicated CAS concn (g/ml)a
0.12 0.25 0.5 1.0 2.0 4.0 8.0 16 32 64
C. albicans 1399          
C. albicans 1954          
C. tropicalis 1490A          
C. tropicalis 1507          
C. orthopsilosis 1238A          
C. orthopsilosis 1825          
C. parapsilosis 1529A          
C. parapsilosis 1856          
a , cell growth; , growth inhibition (fungicidal activity).
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FIG. 1. Time-kill curves of all tested Candida isolates: C. albicans (A and B), C. tropicalis (C and D), C. orthopsilosis (E and F), and C.
parapsilosis (G and H). CAS concentrations used for each species are shown in the respective graphs. The dotted lines represent a 99% growth
reduction compared with the initial inoculum sizes (fungicidal activities).
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cell wall with two layers: (i) an electron-dense outer layer and
(ii) an inner layer of low electron density, continuous with the
plasma membrane (Fig. 5I). In PG cells, a decrease in the
thickness of the inner layer of the cell wall was observed, with
a predominance of the more-electron-dense layer (Fig. 5B, D,
F, H, and J, white arrows). Some PG cells showed what seemed
to be multilayered cell walls or a focal enlargement of the cell
walls (Fig. 5D and H, black arrowheads, respectively).
DISCUSSION
Echinocandins have remarkable in vitro activity against Can-
dida spp., including azole-resistant isolates (11, 23, 31). How-
ever, the emergence of echinocandin resistance during treat-
ment of Candida infections has been reported, and such
resistance is mostly due to mutations in the FKS1 gene (1, 8,
16, 17, 19).
In addition to the possibility that Candida may acquire re-
sistance to echinocandins both in vitro and in vivo by mutation,
it has been shown that PG is not an uncommon phenomenon
in Candida isolates (5, 7, 15, 33). Melo et al. (22) studied the
PG of a number of Candida species in the presence of CAS,
reporting PG frequencies of 83%, 43%, 37.5%, and 25% for C.
tropicalis, C. parapsilosis, C. orthopsilosis, and C. albicans, re-
spectively, in the presence of the drug. Chamilos et al. (7)
observed that, when cells were grown in the presence of CAS,
the prevalence of PG was 90%, 60%, and 40% for C. parapsi-
losis, C. albicans, and C. tropicalis, respectively.
PG has been demonstrated by other authors using a va-
riety of assays, particularly broth microdilution tests for
detecting MICs and MFCs of echinocandins against Can-
FIG. 2. Cell wall components of control and PG cells. (A to C) The absolute values of -1,6- plus -1,3-glucan (A), -1,3-glucan (B), and chitin
(C) of the control and PG cells (black and gray bars, respectively) were expressed as the number of micrograms of carbohydrate per milligram of
dried cell wall. (D) The graph represents the fold change in -1,6- plus -1,3-glucan (black), -1,3-glucan (gray), and chitin (white) contents of
PG cells compared to those of control cells.
FIG. 3. Fluorescence microscopy of C. albicans 1399 control (A
and B) and PG (C and D) cells stained with calcofluor white (CFW).
The value (mean  standard deviation) of the CFW fluorescence
intensity is related to the chitin content of the cell wall (B and D). PG
cells showed regions exhibiting the accumulation of chitin and higher
fluorescence intensity values than those of control cells (P  0.05).
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dida spp. (7, 15, 22). Soczo et al. (33) reported that for C.
tropicalis isolates, PG in CAS was more frequently observed
using MFC assays (93%) than MIC tests (13%). In our
study, MFC assays were helpful in identifying PG for only
the C. albicans and C. tropicalis isolates. Considering that
CAS is usually fungistatic against C. parapsilosis and C.
orthopsilosis strains (3), time-kill curves were more appro-
priate than MFC assays for identifying PG of Candida
FIG. 4. Scanning electron micrographs of Candida strains, comparing control cells and PG cells grown with 16 g/ml of CAS. The values
represent the perimeters of cells (in m; mean  standard deviation). PG cells were larger in size than control cells (P  0.01). Panels I and J
show higher magnifications of panels A and B, respectively; the ring around the constriction between mother cell and bud was noted only in control
cells (arrows). Scale bars, 10 m (A to H) and 5 m (I and J).
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strains in the presence of high concentrations of CAS, es-
pecially for C. parapsilosis and C. orthopsilosis isolates.
Previous reports on the PG effect in the presence of echi-
nocandins have focused on differences among C. albicans
strains. In this study, we have described the ultrastructural and
cell wall biochemical changes that occur in isolates represen-
tative of four clinically relevant Candida species, C. albicans, C.
tropicalis, C. orthopsilosis, and C. parapsilosis, during PG in-
FIG. 5. Transmission electron micrographs of Candida strains, comparing control cells and PG cells grown with 16 g/ml of CAS. Black arrows
indicate the abnormal septa in PG cells. White arrows show the cell walls of control cells, which exhibited two layers, with a predominance of the
more-electron-dense layer in PG cells. Black arrowheads show a multilayered cell wall (D) and a focal enlargement of the cell wall (H) in PG cells.
Panels I and J show higher-magnification electron micrographs of control and PG cells, respectively. (I) As described above, control cells exhibited
cell walls with two layers, an electron-dense outer layer and an inner layer of low electron density. (J) In PG cells, a decrease of inner cell wall
layers and a predominance of the more-electron-dense layers were observed. EC, extracellular environment; C, cytosol. Scale bars, 2 m (A to H)
and 0.2 m (I and J).
308 BIZERRA ET AL. ANTIMICROB. AGENTS CHEMOTHER.
duced by high concentrations of CAS. Our results allow us to
conclude that PG of non-albicans Candida strains induces the
same ultrastructural and biochemical pattern of cell wall
changes as that in C. albicans isolates. PG cells exhibited a
significant decrease in -1,3-glucan content (from 2.7- to 7.8-
fold) and a substantial increase in chitin content (from 4.0- to
6.6-fold) of the cell wall, regardless of the type of Candida
species considered.
With respect to the ultrastructure of PG cells, non-albicans
Candida species and C. albicans strains displayed similar mor-
phology, including enlarged blastospores, clumping of cells, the
absence of filamentation, and abnormalities in constriction
rings between mother and daughter cells. In the cell wall,
untreated cells clearly exhibited two different layers, an outer
cell wall layer with high electron density and an inner layer that
is less electron dense. PG cells showed a decrease in the inner
cell wall layer, which according to Chaffin et al. (6), is com-
posed of -1,3-glucan. Similar results were described by Nish-
iyama et al. (27) when testing micafungin against C. albicans
strains. It is therefore reasonable to suppose that the observed
reduction in the inner cell wall layer is related to the inhibition
of -1,3-glucan synthesis caused by exposition to echinocan-
dins. Our conclusions are supported by fluorescence micros-
copy analysis of cell walls stained with CFW, in which control
cells presented less intense fluorescence and PG cells showed
a strong fluorescence with CFW. These data clearly indicate
that -1,3-glucan is replaced by chitin in PG cells.
Munro et al. (25) demonstrated that chitin synthesis is up-
regulated under conditions in which the integrity of the cell
wall is compromised by antifungal treatments. Walker et al.
(36) showed that low levels of echinocandins stimulated chitin
synthase (CHS) gene expression. Thus, the production of high
levels of chitin seems to reduce the efficacy of echinocandins. It
is therefore suggested that an increase in chitin synthesis dur-
ing CAS treatment may play a key role in mediating resistance
to echinocandins.
It is not yet fully understood whether the morphological and
biochemical modifications exhibited by PG cells confer a fit-
ness disadvantage or contribute to antifungal therapy failure
during treatment with high doses of echinocandin. It is well
known that -1,3-glucan plays a critical role in the mainte-
nance of cell shape, mechanical rigidity, and resistance to os-
motic pressure (6). The reduction in -1,3-glucan observed in
PG cells suggests that PG cells are osmotically fragile, resulting
in morphological alteration; this could possibly lead to a fitness
disadvantage for these cells. Moreover, it is known that in
yeast, virulence factors are expressed mainly during filamen-
tous growth stages. Because PG cells do not present a filamen-
tous form, this could justify a decrease in virulence factor
expression and a consequent loss of infectivity in these cells.
The clinical significance of the occurrence of PG during
echinocandin therapy is not well understood. Although animal
models have failed to demonstrate PG in murine models of
systemic Candida infection (9, 21), these data require further
detailed analysis. It is worth mentioning that a randomized
comparative study of two different micafungin dosages con-
ducted by Pappas et al. (28) clearly demonstrated that candi-
demic patients treated with high doses of micafungin (150
mg/day) did not show any improvement compared to patients
treated with a regular dosage (100 mg/day). Those authors
reported that 14 of 30 patients (47%) with deep-seated infec-
tions treated with 150 mg/day micafungin had treatment failure
compared to only 6 of 28 patients (21%) in the 100 mg/day
micafungin group and suggested that the lower rate of success
among patients treated with 150 mg/day micafungin could pos-
sibly be explained by the PG effect. Further studies using non-
candidemic models will be needed to determine whether PG
contributes to human disease in vivo.
Although the clinical significance of PG remains unclear, the
elucidation of the morphological, biochemical, and molecular
pathways underlying this phenomenon is likely to contribute to
a better understanding of novel cellular mechanisms that may
be involved in rescue against echinocandin antifungal activity.
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